The protective effect of cardiac gene transfer of CuZn-sod in comparison with the cardioprotector monohydroxyethylrutoside against doxorubicin-induced cardiotoxicity in cultured cells

Cancer Gene Therapy

Volumn 10, Issue 4, 2003, Pages 270-277

  Abou El Hassan, M A I ^a,c   Heijn, M ^a   Rabelink, M J W E ^c   Van der Vijgh, W J F ^a   Bast, A ^b   Hoeben, R C ^c  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Adenovirus; CuZn sod; Doxorubicin; MonoHER; MTT; Neonatal cardiac myocytes

Indexed keywords

ADENOVIRUS VECTOR; COPPER ZINC SUPEROXIDE DISMUTASE; DOXORUBICIN; FREE RADICAL; LACTATE DEHYDROGENASE; MONOXERUTIN; RUTOSIDE DERIVATIVE;

ANIMAL CELL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CARDIOTOXICITY; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; ENZYME ACTIVITY; ENZYME RELEASE; GENE TRANSFER; HEART BEAT; HEART MUSCLE CELL; HEART PROTECTION; HEART RATE; NEWBORN; NONHUMAN; PLAQUE FORMING CELL; PRIORITY JOURNAL; RAT;

ADENOVIRIDAE; ANIMALS; ANIMALS, NEWBORN; CARDIOTONIC AGENTS; CELL SURVIVAL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; GENETIC VECTORS; HYDROXYETHYLRUTOSIDE; L-LACTATE DEHYDROGENASE; MICE; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDE DISMUTASE;

ADENOVIRIDAE; ANIMALIA; MUS MUSCULUS;

EID: 0037385412     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700564     Document Type: Article

References (37)

1. Goeptar AR, Te Koppele JM, Lamme EK, et al. Cytochrome P-450 2BI-mediated one-electron reduction of adriamycin: a study with rat liver microsomes and purified enzymes. Mol Pharmacol. 1993;44:1267-1277.
2. Goeptar AR, Groot EJ, Scheerens H, et al. Cytotoxicity of mitomycin C and adriamycin in freshly isolated rat hepatocytes: the role of cytochrome P450. Cancer Res. 1994;54:2411-2418.
3. Minotti G. Adriamycin-dependent release of iron from microsomal membranes. Arch Biochem Biophys. 1989;268:398-403.
4. Van Acker SABE, Boven E, Kuiper K, et al. Monohyroxyethylrutoside, a dose dependent cardioprotective agent, does not affect the antitumor activity of doxorubicin. Clin Cancer Res. 1997;3:1747-1754.
5. Van Acker FAA, Van Acker SABE, Kramer K, et al. MonoHER protects against chronic doxorubicin-induced cardiotoxicity when administered only once per week. Clin Cancer Res. 2000;6(4):1337-1341.
6. Koning J, Palmer P, Franks CR, et al. Cardioxane-ICRF-187. Towards anticancer drug specificity through selective toxicity reduction. Cancer Treat Rev. 1991;18:1-19.
7. Van Acker SABE, Van den Berg D, Tromp MNJL, et al. Structural aspects of the antioxidant activity of flavonoids. Free Rad Biol Med. 1996;20:331-342.
8. Van Acker SABE, Van Balen GP, Van den Berg D, et al. Influence of iron chelation on the antioxidant activity of flavonoids. Biochem Pharmacol. 1998;56:935-943.
9. Keizer HG, Pinedo HM, Schuurhuis GJ, et al. Doxorubicin (adriamycin): a critical review of free radical-dependent mechanisms of cytotoxicity. Pharmacol Ther. 1990;47:219-231.
10. Lin TJ, Liu GT, Pan Y, et al. Protection by schisanhenol against adriamycin toxocity in rat heart mitochondria. Biochem Pharmacol. 1991;42:1805-1810.
11. Green MD, Alderton P, Gross J, et al. Evidence of the selective alteration of anthracyclines activity due to modulation by ICRF-187 (ADR-529). Pharmacol Ther. 1990;48:61-69.
12. Takacs IE, Matkovics B, Varga SI, et al. Study of the myocardial antioxidant defense in various species. Pharmacol Res. 1992;25:177-178.
13. Fridovich I. The biology of oxygen radicals. The superoxide radical is an agent of oxygen toxicity: superoxide dismutase provide an important defence. Science. 1978;201:875-880.
14. Deshmukh DR, Mirochnitchenko O, Ghole VS, et al. Intestinal ischemia and reperfusion injury in transgenic mice overexpressing copper-zinc superoxide dismutase. Am J Physiol. 1997;273:C1130-C1135.
15. Sarvazyan NA, Askari A, Huang W-H. Effects of doxorubicin on cardiomyocytes with reduced level of superoxide dismutase. Life Sceince. 1995;57:1003-1010.
16. Yen H-C, Oberley TD, Vichitbandha S, et al. The protective role of manganese superoxide dismutase against adriamycin-induced acute cardiac toxicity in transgenic mice. J Clin Invest. 1996;98:1253-1260.
17. Yen H-C, Oberley TD, Gairola CG, et al. Manganese superoxide dismutase protects mitochondrial complex I against adriamycin-induced cardiomyopathy in transgenic mice. Arch Biochem Biophys. 1999;362:59-66.
18. Danel C, Erzurum SC, Prayssac P, et al. Gene therapy for oxidant injury-related diseases: adenovirus-mediated transfer of superoxide dismutase and catalase cDNA protects against hyperoxia but not against ischemia-reperfusion lung injury. Hum Gene Ther. 1998;9:1487-1496.
19. Bett AJ, Krougliak V, Graham FL. DNA sequence of the deletion/insertion in early region 3 of Ad5 d1309. Virus Res. 1995;39:75-82.
20. McGrory WJ, Bautista DS, Graham FL. A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5. Virology. 1988;163:614-617.
21. Fallaux FJ, Bout A, Van der Velde I, et al. New helper cells and matched early region 1-deleted adenoviral vectors prevent generation of replication-competent adenoviruses. Hum Gene Ther. 1998;9:1909-1917.
22. Fallaux FJ, Kranenburg O, Cramer SJ, et al. Characterisation of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors. Hum Gene Ther. 1996;7:215-211.
23. Pietersen AM, Van der Eb MM, Rademaker HJ, et al. Specific tumor-cell killing with adenovirus vectors containing the appoptic gene. Gene Ther. 1999;6:882-892.
24. Van Wamel JET, Ruwhof C, Van der Valk-Kokshoorn EJM, et al. Rapid gene transcription induced by stretch in cardiac myocytes and fibroblasts and their paracrine influence on stationary myocytes and fibroblasts. Eur J Physiol. 2000;439:781-788.
25. McCord JM, Fridovich I. The utility of superoxide dismutase in studying free radical reactions. J Biol Chem. 1969;22:6056-6063.
26. Moldeus P, Hogberg J, Orreniu S. Isolation and use of liver cells. Methods Enzymol. 1978;52:60-71.
27. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55-63.
28. Konorev EA, Kennedy MC, Kalyanaraman. Cell-permeable superoxide dismutase and glutathione peroxidase mimetics afford superior protection against doxorubicin-induced cardiotoxicity: the role of reactive oxygen and nitrogen intermediates. Arch Biochem Biophys. 1999;368:421-428.
29. Villani F, Galimberti M, Poggi P, et al. The effect of superoxide dismutase and catalse on the delayed toxicity of doxorubicin. Cardiologia. 1992;37:709-711.
30. Hess ML, Kukreja RC. Free radicals, calcium homeostasis, heat shock proteins and myocardial stunning. Ann Thorac Surg. 1995;60:760-766.
31. Kukreja RC, Janin YJ. Perfusion injury: basic concepts and protection strategies. J Thromb Thrombolysis. 1997;4:7-24.
32. Wang P, Chen H, Qin H, et al. Overexpression of human copper, zinc-superoxide dismutase (sod1) prevents postischemic injury. Proc Natl Acad Sci. 1998;95:4556-4560.
33. Moriscot C, Pattou F, Kerr-Conte J, et al. Contribution of adenoviral-mediated superoxide dismutase gene transfer to the reduction in nitric oxide-induced cytotoxicity on human islets and INS-1 insulin-secreting cells. Diabetologia 2000;43:625-631.
34. Crawford LE, Milliken EE, Irani K, et al. Superoxidemediated actin responce in post-hypoxic endothelial cells. J Bio Chem. 1996;271:26863-26867.
35. 2, but also by potentiating the catalytic activity of ferrous ions. Toxicol Lett. 1984;22:153-159.
36. Cini Neri G, Neri B, Bandinelli M, et al. Anthracycline cardiotoxicity: in vivo and in vitro effects on biochemical parameters and heart ultrastructure of the rat. Oncology. 1991;48:327-333.
37. Wagner H. New plant phenolic of pharmaceutical interest. Ann Proc Phytochem Soc Eur. 1985;25:409-425.